Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Cervical cancer caused by human papillomavirus (HPV) infections is the fourth most common cancer in women worldwide. Current prophylactic HPV vaccines have achieved promising success in preventing HPV infection. However, still 570,000 new cases were reported in 2018. The current primary treatment fo...

Full description

Bibliographic Details
Main Authors: Bilian Huang, Linjing Zhu, Hongxia Wei, Haixia Shi, Doudou Zhang, Huanyun Yuan, Linlin Luan, Nan Zheng, Shijie Xu, Waqas Nawaz, Ying Hong, Xilin Wu, Zhiwei Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
HPV18
cervical cancer
neutralizing antibodies
topical agents
humanized antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.678318/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.678318/full

Similar Items